Company / Operating Cash Flow per Share
Maze Therapeutics, Inc. Operating Cash Flow per Share History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$45.75
FY2025
5-year range
-$45.75 / -$45.75
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#210 of 212
Health Care
What the data says
Among 212 Health Care companies, Maze Therapeutics, Inc. is in the bottom 1% for operating cash flow per share.
Based on SEC 10-K filings.
-45.75 in FY2025.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 212This company -$45.75 Sector average -$14.72
▼
-210.7% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$45.75 | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026